120 related articles for article (PubMed ID: 23069585)
21. α
Romero TRL; Miranda E Castor MG; Parrella C; Piscitelli F; Di Marzo V; Duarte IDG
Pharmacol Rep; 2020 Feb; 72(1):96-103. PubMed ID: 32016857
[TBL] [Abstract][Full Text] [Related]
22. Modifications of the ethanolamine head in N-palmitoylethanolamine: synthesis and evaluation of new agents interfering with the metabolism of anandamide.
Vandevoorde S; Jonsson KO; Fowler CJ; Lambert DM
J Med Chem; 2003 Apr; 46(8):1440-8. PubMed ID: 12672243
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms.
Chang L; Luo L; Palmer JA; Sutton S; Wilson SJ; Barbier AJ; Breitenbucher JG; Chaplan SR; Webb M
Br J Pharmacol; 2006 May; 148(1):102-13. PubMed ID: 16501580
[TBL] [Abstract][Full Text] [Related]
24. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on modulation of nociception in a rat model of cholestasis.
Hasanein P; Shahidi S; Komaki A; Mirazi N
Eur J Pharmacol; 2008 Sep; 591(1-3):132-5. PubMed ID: 18593578
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo pharmacology of synthetic olivetol- or resorcinol-derived cannabinoid receptor ligands.
Cascio MG; Bisogno T; Palazzo E; Thomas A; van der Stelt M; Brizzi A; de Novellis V; Marabese I; Ross R; van de Doelen T; Brizzi V; Pertwee R; Maione S; Di Marzo V
Br J Pharmacol; 2006 Oct; 149(4):431-40. PubMed ID: 16953186
[TBL] [Abstract][Full Text] [Related]
26. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat.
Craft RM; Wakley AA; Tsutsui KT; Laggart JD
J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934
[TBL] [Abstract][Full Text] [Related]
27. Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia.
Lichtman AH; Shelton CC; Advani T; Cravatt BF
Pain; 2004 Jun; 109(3):319-327. PubMed ID: 15157693
[TBL] [Abstract][Full Text] [Related]
28. Antinociceptive effects of racemic AM1241 and its chirally synthesized enantiomers: lack of dependence upon opioid receptor activation.
Rahn EJ; Zvonok AM; Makriyannis A; Hohmann AG
AAPS J; 2010 Jun; 12(2):147-57. PubMed ID: 20127295
[TBL] [Abstract][Full Text] [Related]
29. Design, synthesis, and binding studies of new potent ligands of cannabinoid receptors.
Brizzi A; Brizzi V; Cascio MG; Bisogno T; Sirianni R; Di Marzo V
J Med Chem; 2005 Nov; 48(23):7343-50. PubMed ID: 16279794
[TBL] [Abstract][Full Text] [Related]
30. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
[TBL] [Abstract][Full Text] [Related]
31. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2) cannabinoid receptor.
Cox ML; Haller VL; Welch SP
Eur J Pharmacol; 2007 Sep; 570(1-3):50-6. PubMed ID: 17588560
[TBL] [Abstract][Full Text] [Related]
32. Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats.
Schreiber AK; Neufeld M; Jesus CH; Cunha JM
Neuropharmacology; 2012 Dec; 63(8):1286-97. PubMed ID: 22959964
[TBL] [Abstract][Full Text] [Related]
33. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
Desroches J; Charron S; Bouchard JF; Beaulieu P
Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
[TBL] [Abstract][Full Text] [Related]
34. Fatty acid amide hydrolase-dependent generation of antinociceptive drug metabolites acting on TRPV1 in the brain.
Barrière DA; Mallet C; Blomgren A; Simonsen C; Daulhac L; Libert F; Chapuy E; Etienne M; Högestätt ED; Zygmunt PM; Eschalier A
PLoS One; 2013; 8(8):e70690. PubMed ID: 23940628
[TBL] [Abstract][Full Text] [Related]
35. The effects of peptide and lipid endocannabinoids on arthritic pain at the spinal level.
Petrovszki Z; Kovacs G; Tömböly C; Benedek G; Horvath G
Anesth Analg; 2012 Jun; 114(6):1346-52. PubMed ID: 22451592
[TBL] [Abstract][Full Text] [Related]
36. Palmitic acid analogues exhibiting antinociceptive activity in mice.
Déciga-Campos M; Montiel-Ruiz RM; Navarrete-Vázquez G; López-Muñoz FJ
Proc West Pharmacol Soc; 2007; 50():75-7. PubMed ID: 18605236
[TBL] [Abstract][Full Text] [Related]
37. The antinociceptive triterpene β-amyrin inhibits 2-arachidonoylglycerol (2-AG) hydrolysis without directly targeting cannabinoid receptors.
Chicca A; Marazzi J; Gertsch J
Br J Pharmacol; 2012 Dec; 167(8):1596-608. PubMed ID: 22646533
[TBL] [Abstract][Full Text] [Related]
38. Involvement of opioid receptors in the systemic and peripheral antinociceptive actions of ellagic acid in the rat formalin test.
Mansouri MT; Naghizadeh B; Ghorbanzadeh B
Pharmacol Biochem Behav; 2014 May; 120():43-9. PubMed ID: 24561064
[TBL] [Abstract][Full Text] [Related]
39. Curcumin induces peripheral antinociception by opioidergic and cannabinoidergic mechanism: Pharmacological evidence.
Aguiar DD; Gonzaga ACR; Teófilo ALH; Miranda FA; Perez AC; Duarte IDG; Romero TRL
Life Sci; 2022 Mar; 293():120279. PubMed ID: 35032552
[TBL] [Abstract][Full Text] [Related]
40. Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception.
Naidu PS; Booker L; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2009 Apr; 329(1):48-56. PubMed ID: 19118134
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
